Join

Compare · BIS vs RICE

BIS vs RICE

Side-by-side comparison of ProShares UltraShort Nasdaq Biotechnology (BIS) and Rice Acquisition Corp. (RICE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both BIS and RICE operate in n/a (n/a), so they compete in similar markets.
  • RICE carries a market cap of $536.2M.
  • RICE has more recent analyst coverage (1 ratings vs 0 for BIS).
MetricBISRICE
Company
ProShares UltraShort Nasdaq Biotechnology
Rice Acquisition Corp.
Price
$8.61+1.77%
$18.23+0.52%
Market cap
-
$536.2M
1M return
-12.05%
-
1Y return
-53.21%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NYSE
IPO
n/a
2020
News (4w)
0
0
Recent ratings
0
1
BIS

ProShares UltraShort Nasdaq Biotechnology

The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

RICE

Rice Acquisition Corp.

Rice Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Carnegie, Pennsylvania.

Latest BIS

Latest RICE